Use of igf-1 and nt-3 in the treatment of x-linked adrenoleukodystrophy

The present invention is directed to new compositions uses thereof and related methods for the treatment of X- linked adrenoleukodystrophy.


Year:
2010
Other identifiers:
TTO: 6.0880
EPO Family ID: 42104387
Patent number(s):
Laboratories:




 Record created 2015-09-22, last modified 2018-09-13


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)